Application 020636
- Type
- NDA
- Sponsor
- BOEHRINGER INGELHEIM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VIRAMUNE | NEVIRAPINE | TABLET;ORAL | 200MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020636-001 | VIRAMUNE | NEVIRAPINE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1996-06-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N020636-001 | VIRAMUNE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1996-06-21 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NEVIRAPINE | NEVIRAPINE | Micro Labs Limited | fbd628db-4076-4fe0-8323-9cc33ae92e42 | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Mylan Pharmaceuticals Inc. | 690da74b-2481-47fc-93ae-8340e0caf0a4 | 2024-10-15 | Boxed warning, Warnings, Adverse reactions | NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Aurobindo Pharma Limited | 8dfe86aa-ea5d-48d2-94a8-1a5506055d70 | 2024-09-04 | Boxed warning, Warnings, Adverse reactions | NEVIRAPINE |
| NEVIRAPINE | NEVIRAPINE | Macleods Pharmaceuticals Limited | 2620b114-f53f-44f1-8708-697e86343090 | 2024-08-14 | Boxed warning, Warnings, Adverse reactions | NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Aurobindo Pharma Limited | 5f6c3eed-2a5d-46ed-9a7c-59715f338a15 | 2024-05-20 | Boxed warning, Warnings, Adverse reactions | NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Mylan Pharmaceuticals Inc. | c6e93829-7024-48f6-8023-da6ff27dfc0a | 2024-01-15 | Boxed warning, Warnings, Adverse reactions | NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Macleods Pharmaceuticals Limited | effb86cc-4b80-4fac-aaa3-9f373b3d0f7d | 2023-08-16 | Boxed warning, Warnings, Adverse reactions | NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Camber Pharmaceuticals, Inc. | 61409678-d2f6-42cd-b03d-b26b11b39641 | 2022-08-03 | Boxed warning, Warnings, Adverse reactions | NEVIRAPINE |
| Nevirapine | NEVIRAPINE | Amneal Pharmaceuticals LLC | 4f065674-4719-4c79-ba0d-549040d77f17 | 2012-08-30 | Boxed warning, Warnings, Adverse reactions | NEVIRAPINE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0597-0046 | Viramune | nevirapine | Boehringer Ingelheim Pharmaceuticals Inc. | NDA | Current |
| 0597-0046 | Viramune | nevirapine | Boehringer Ingelheim Pharmaceuticals Inc. | NDA | Current |
| 0597-0046 | Viramune | nevirapine | Boehringer Ingelheim Pharmaceuticals Inc. | NDA | Current |
| 53808-0808 | Viramune | nevirapine | State of Florida DOH Central Pharmacy | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 71313 | SUPPL | 2022-06-15 |
| 71312 | SUPPL | 2022-06-15 |
| 71284 | SUPPL | 2022-06-13 |
| 57682 | ORIG | 2019-02-15 |
| 55742 | SUPPL | 2018-10-01 |
| 55615 | SUPPL | 2018-09-25 |
| 55613 | SUPPL | 2018-09-25 |
| 47768 | SUPPL | 2017-03-29 |
| 47735 | SUPPL | 2017-03-28 |
| 25413 | SUPPL | 2014-01-28 |
| 12906 | SUPPL | 2014-01-28 |
| 35050 | SUPPL | 2012-11-15 |
| 25412 | SUPPL | 2012-11-13 |
| 2966 | SUPPL | 2011-11-14 |
| 35049 | SUPPL | 2011-11-10 |
| 25411 | SUPPL | 2011-05-10 |
| 2965 | SUPPL | 2011-03-31 |
| 12905 | SUPPL | 2011-03-28 |
| 25410 | SUPPL | 2011-01-14 |
| 35048 | SUPPL | 2011-01-10 |
| 2964 | SUPPL | 2010-07-23 |
| 35047 | SUPPL | 2010-07-22 |
| 25409 | SUPPL | 2010-01-26 |
| 12904 | SUPPL | 2010-01-20 |
| 2963 | SUPPL | 2008-06-30 |
| 35045 | SUPPL | 2008-06-26 |
| 35046 | SUPPL | 2007-08-17 |
| 25408 | SUPPL | 2007-08-17 |
| 41513 | SUPPL | 2007-08-06 |
| 20797 | SUPPL | 2007-08-06 |
| 20795 | SUPPL | 2007-08-06 |
| 20793 | SUPPL | 2007-08-06 |
| 20792 | SUPPL | 2007-08-06 |
| 25407 | SUPPL | 2007-04-20 |
| 12903 | SUPPL | 2007-04-20 |
| 20796 | SUPPL | 2005-04-27 |
| 35044 | SUPPL | 2005-03-02 |
| 2962 | SUPPL | 2005-03-02 |
| 35040 | SUPPL | 2004-06-30 |
| 25404 | SUPPL | 2004-06-30 |
| 25403 | SUPPL | 2004-06-30 |
| 12902 | SUPPL | 2004-05-27 |
| 2961 | SUPPL | 2004-05-26 |
| 20794 | SUPPL | 2004-02-04 |
| 35043 | SUPPL | 2003-12-29 |
| 2960 | SUPPL | 2003-12-23 |
| 35042 | SUPPL | 2003-08-06 |
| 25406 | SUPPL | 2003-08-06 |
| 35041 | SUPPL | 2003-04-04 |
| 25405 | SUPPL | 2002-03-27 |